NewslettersPulmonary Cell NewsMSD, Moderna Start Phase III Adjuvant Lung Cancer TrialBy lbeveridge - October 29, 20240300MSD and Moderna have kicked off another Phase III trial of their personalised cancer vaccine V940 used alongside MSD’s PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage NSCLC.[PharmaPhorum]Press Release